Nephrocare Health Services approved the rationalisation and consolidation of its step-down subsidiaries in the Philippines on September 18, 2026. The move aims to simplify the corporate structure and enhance operational efficiency.

The Board of Directors sanctioned the proposal during a meeting held on Friday, September 18, 2026. The decision is subject to compliance with applicable laws and receipt of necessary statutory, regulatory, corporate, and other approvals in India and the Philippines.

Structural Rationalisation

The company operates its Philippine business through Nephrocare Health Care Services Philippines, Inc., a step-down subsidiary held via Nephrocare Health Services International Pte. Ltd. in Singapore. The group currently uses multiple wholly-owned subsidiaries for these operations.

The proposed consolidation will reduce the number of operating entities. Management stated this internal reorganisation is intended to streamline administrative and compliance processes, optimise costs, and strengthen governance oversight. The simplified structure is designed to be more scalable and aligned with the company’s international growth strategy.

No Change in Control

The transaction involves no third-party investors. There will be no change in the shareholding pattern of Nephrocare Health Services or in the ultimate ownership and control of the Philippine business.

Nephrocare PH will remain a step-down subsidiary through the Singapore entity. The company plans to account for the transaction as a common-control transaction under the applicable accounting framework. The restructuring does not envisage any specific benefit to the promoter or promoter group.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company referenced SEBI Master Circular Ref. No. HO/49/14/14(7)2025-CFDPOD2/ I/3762/2026 dated January 30, 2026.

Further updates regarding the rationalisation will be disclosed as required under the listing regulations.

Nephrocare Health Services has acquired dialysis center assets in the Philippines for ₹10.25 crore. The deal, executed on September 14, 2026, involves its wholly owned overseas subsidiary and marks an expansion of its international footprint.

The transaction targets identified assets of a dialysis center located at Unit 6, Rockca Commercial Complex, Brgy. Tabang, Plaridel, Bulacan. The total consideration is PHP 67,200,000, converted at an exchange rate of 1 PHP = INR 1.5248. The seller, Renal One Dialysis Corp, is unrelated to the promoter group or group companies.

Transaction Details

The agreement was disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. Kishore Kathri, Company Secretary and Head Legal, signed the disclosure on behalf of the company.

Strategic Context

This asset purchase allows Nephrocare to integrate existing operational dialysis infrastructure into its network without building from scratch. No special rights, such as board appointments or share subscription preferences, were attached to the agreement.